ADDIRA

INDICATED IN:

In Benign Prostatic Hyperplasia (BPH).

• Silodosin

  Silodosin is an alpha-Adrenergic Blocker. The mechanism of action of silodosin is as an Adrenergic alpha-Antagonist. Silodosin is a selective alpha-1a adrenergic antagonist used in the therapy of benign prostatic hypertrophy. Blockade of these receptors causes smooth muscle relaxation, lowers intraurethral pressure, and results in improved urine flow and a reduction in the symptoms of BPH, such as difficulty with urinating, painful urination, urinary frequency and incomplete bladder emptying.

• Dutasteride

  Dutasteride is a 5-alpha reductase inhibitor used in the therapy of symptomatic benign prostatic hypertrophy in men with an enlarged prostate gland.

ADDIRA 4/8 works by relaxing the muscle around the bladder exit and prostate gland so as to allow easy passage of urine. ADDIRA-D8 is a combination of two medicines: Silodosin and Dutasteride, which relieves the symptoms of benign prostatic hyperplasia. It helps to relieve symptoms such as difficulty urinating or urge to urinate more often and improve your ability to urinate.